Lyon, France, September 7th, 2020 – 6:00 pm CEST – Adocia (Euronext Paris: FR0011184241 – ADOC), a clinical stage biopharmaceutical company focused on the treatment of diabetes and other metabolic diseases with innovative formulations of proteins and peptides, announced today that CEO, Gérard Soula, will present a company overview at the H.C. Wainwright 22nd Annual Global Investment Conference, held virtually this year, September 14-16, 2020.
Presenter: Gérard Soula, CEO
Presentation Day: September 15, 2020
Time: 1:00 PM (EDT) / 7:00 PM (CEST)
Link to the online presentation (live and archived for 90 days)